Literature DB >> 34935104

Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain.

Chris Skedgel1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34935104     DOI： 10.1007/s40273-021-01119-1

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers.

Authors:  C Simone Sutherland; Pollyanna Hudson; Stephen Mitchell; Noman Paracha
Journal:  Pharmacoeconomics       Date:  2021-12-15       Impact factor: 4.981

2.  Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries.

Authors:  Siu Hing Lo; Claire Lawrence; Yasmina Martí; Andreia Café; Andrew J Lloyd
Journal:  Pharmacoeconomics       Date:  2021-12-13       Impact factor: 4.981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.